awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40403542-724B6C83-B41A-440A-8A83-F41977BCDFCD
Q40403542-724B6C83-B41A-440A-8A83-F41977BCDFCD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40403542-724B6C83-B41A-440A-8A83-F41977BCDFCD
Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation.
P2860
Q40403542-724B6C83-B41A-440A-8A83-F41977BCDFCD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40403542-724B6C83-B41A-440A-8A83-F41977BCDFCD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0402b899df1463763fcf22d477891fc982eb1760
P2860
Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL.